Insilico Medicine Launches Industry’s First Drug Discovery Benchmark-as-a-Service for Frontier AI Models
Insilico Medicine has launched what it describes as the first Drug Discovery and Development Benchmark as a Service, a testing...
Louis Brooks is a Scienmag editorial specialist profile for Medicinal Chemistry coverage.
Insilico Medicine has launched what it describes as the first Drug Discovery and Development Benchmark as a Service, a testing...
Tuberculosis drug discovery gets smarter with AI at Texas A&M AgriLife New tools help researchers move faster against a global...
Binghamton University chemists have discovered a new mechanism that could potentially lead to quicker outcomes in pharmaceutical research. Carbon-halogen bonds...
Revolver Therapeutics, a University of Bath spin-out building a new class of drug discovery tools, has won the Health category...
Viral Science News A new phase I clinical study has mapped how two widely discussed drugs—ticagrelor and fazamorexant—may interact in...
Insilico Medicine founders Dr. Alex Zhavoronkov and Dr. Feng Ren have been invited to the inaugural China Pioneer Innovative Drug...
TUCSON, Ariz., July 16, 2026 — Critical Path Institute’s® (C-Path) New Approach Methodologies Developer Coalition (NAMs-DC) has added Crown Bioscience...
Glioblastoma remains one of the deadliest brain cancers, notorious for its resistance to standard therapy and its ability to adapt...
Insilico Medicine, a clinical-stage generative AI drug discovery company, has announced a multi-target strategic alliance with Bora Pharmaceuticals, a global...
In a groundbreaking advancement for targeted drug delivery, an international team of scientists has successfully combined asymmetric-flow field-flow fractionation (AF4)...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine